Company: SLNH
Filing Date: 2025-06-16
Form Type: S-1/A
Source: 0001641172-25-015179
Chunk: 49

Company: Soluna Holdings, Inc
Filing Date: 2025-06-16
Form: S-1/A
Chunk 49
---
, 2022, we and the purchasers (the
“October 2021 Purchasers”) listed in the Securities Purchase Agreement dated October 25, 2021 (the “October 2021 SPA”),
entered into an agreement (the “Addendum Amendment”) further amending the Addendum, dated July 19, 2022, pursuant to which,
among other things, we issued to the October 2021 Purchasers 430,564 shares of common stock (“New Shares”) in exchange for
Class B warrants issued in connection with the October 2021 SPA, and Class D warrants to purchase up to an aggregate of 1,000,000 shares of common stock , Class E common stock purchase warrants to purchase up to an aggregate of 1,000,000 shares of common stock , Class F common stock purchase warrants to purchase up to an aggregate of 1,000,000 shares of common stock , and Class G common stock purchase warrants to purchase up to an aggregate of 1,000,000 shares of common stock (together, the “New Warrants”). The New Shares and
the New Warrants were issued without registration under the Securities Act, based on the exemption from registration afforded by Section
4(a)(2) of the Securities Act and/or Rule 506 promulgated thereunder.

On December 2, 2022, we entered into a placement
agency agreement (the “Placement Agency Agreement”) with Univest Securities, LLC (“Univest”), pursuant to which
Univest agreed to serve as the exclusive placement agent for us in connection with such offering. Pursuant to the Placement Agency Agreement,
we agreed to pay Univest 431,014 restricted shares of common stock in relation to Univest’s role in the underwritten offering that
closed on October 26, 2022 (the “October Shares”). The October Shares were issued without registration under the Securities
Act, in reliance on the exemptions from registration provided by Section 4(a)(2) under the Securities Act.

On May 23, 2023, we entered into a Subscription
and Investment Representation Agreement with David Michaels, our Secretary (the “Subscriber”), and sold to the Subscriber
one share of our Series X Preferred Stock, par value $0.001 per share (the “Series X Preferred Stock”). The offering and sale
of the Series X Preferred Stock was exempt from registration under Section 4(a)(2) of the Securities Act.

On July 28, 2023